Clinical Trial Developments in the Concussions Market
Clinical trials in the Concussions Market are increasingly focused on validating new diagnostic biomarkers and therapeutic interventions. Trials evaluating the efficacy of non-invasive brain monitoring devices and neuroprotective agents are underway.
Moreover, virtual reality-based rehabilitation programs are being tested for their effectiveness in improving cognitive and motor recovery post-concussion. Enhanced patient recruitment through digital platforms and multicenter collaboration is accelerating trial progress, promising faster translation of innovations into clinical practice.
2 Views